| Fund ID | 805-9545480985 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 40% |
| Fund | Type | Gross assets |
|---|---|---|
| Ally Bridge Group-Wtt Global Life Science Capital Partners, L.P. | Private Equity | $616.3M |
| Ally Bridge Group Global Life Science Capital Partners V, L.P. | Private Equity | $266.5M |
| Ally Bridge Group Capital Partners II, L.P. | Private Equity | $132.9M |
Abg-Siv, L.P. reports $5 million in gross assets, among the top 85% of private funds by size.
The stated minimum investment is $100,000.
Abg-Siv, L.P. is managed by Ally Bridge Group (pe) LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.